{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:17:13Z","timestamp":1791908233964,"version":"4.3.4"},"reference-count":46,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jbcpp-2020-0107_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      The objective of this study is to explore the efficacy and safety of\n                      <jats:italic>N<\/jats:italic>\n                      -acetyl-cysteine (NAC) as adjuvant therapy in female infertility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2020-0107_abs_002\">\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>We performed a systematic literature search of PubMed, Cochrane Library, Embase, and Ovid databases through April 2019 for Randomized Controlled Trials (RCTs) evaluating the effectiveness and safety of NAC as adjuvant therapy in female infertility. The outcomes assessed were rates of ovulation, pregnancy, miscarriage and multiple pregnancy, presented as pooled odds ratio with 95% confidence interval (CI) using the random-effects model. Heterogeneity and inconsistency of the measurements were identified through Cochrane\u2019s Q statistic and I2 statistic. We also performed a sensitivity analysis, publication bias (using funnel plot and Begg\u2019s test), and subgroup analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2020-0107_abs_003\">\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Fifteen RCTs recruiting 2330 female receiving NAC were included. The pooled estimate showed the statistically insignificant improvement in outcomes; clinical pregnancy rate 1.55 (95% CI 0.98\u20132.47; I2=68%; p&lt;0.01), ovulation rate 1.77 (95% CI 0.76\u20134.14; I2=90%; p&lt;0.01), multiple pregnancy rate 0.83 (95% CI 0.34\u20131.99; I2=10%; p=0.31) and miscarriage rate 0.76 (95% CI= 0.37, 1.53; I2=0%; p=0.69) . NAC was found less efficacious and safe than metformin in all outcomes. Overall, NAC showed statistically insignificant (OR=0.98\u20132.47).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2020-0107_abs_004\">\n                    <jats:title>Outlook<\/jats:title>\n                    <jats:p>NAC can be an effective adjuvant in PCOS related and unexplained female infertility. The effect could be more profound in women with high BMI, insulin resistance, and oxidative stress. However, the findings need further confirmation in well-designed randomized controlled trials to examine clinical outcomes such as live birth rate in more extended follow-up periods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jbcpp-2020-0107","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T15:48:33Z","timestamp":1606751313000},"page":"899-910","source":"Crossref","is-referenced-by-count":20,"title":["<i>N<\/i>\n                    -acetyl-cysteine as adjuvant therapy in female infertility: a systematic review and meta-analysis"],"prefix":"10.1515","volume":"32","author":[{"given":"Nagita","family":"Devi","sequence":"first","affiliation":[{"name":"Pharmacy Practice , National Institute of Pharmaceutical Education and Research , SAS Nagar , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekhar","family":"Boya","sequence":"additional","affiliation":[{"name":"Pharmacy Practice , National Institute of Pharmaceutical Education and Research , SAS Nagar , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8924-8242","authenticated-orcid":false,"given":"Manik","family":"Chhabra","sequence":"additional","affiliation":[{"name":"Pharmacy Practice , National Institute of Pharmaceutical Education and Research , SAS Nagar , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Bansal","sequence":"additional","affiliation":[{"name":"Pharmacy Practice , National Institute of Pharmaceutical Education and Research , SAS Nagar , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_001","unstructured":"WHO. Sexual and reproductive health 2019. Available from: https:\/\/www.who.int\/reproductivehealth\/topics\/infertility\/perspective\/en\/ [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_002","unstructured":"Trust NHS. Centre for reproductive medicine; 2019. Available from: https:\/\/www.uhcw.nhs.uk\/clientfiles\/files\/IVF\/patient%20info%20booklet%20(GEN-PI-000014V6).pdf [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_003","doi-asserted-by":"crossref","unstructured":"Escobar-Morreale, HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018;14:270\u201384. https:\/\/doi.org\/10.1038\/nrendo.2018.24.","DOI":"10.1038\/nrendo.2018.24"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_004","doi-asserted-by":"crossref","unstructured":"Shannon, M, Wang, Y. Polycystic ovary syndrome: a common but often unrecognized condition. J Midwifery Womens Health 2012;57:221\u201330. https:\/\/doi.org\/10.1111\/j.1542-2011.2012.00161.x.","DOI":"10.1111\/j.1542-2011.2012.00161.x"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_005","doi-asserted-by":"crossref","unstructured":"Kamath, MS, George, K. Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate. Reprod Biol Endocrinol 2011;9:86. https:\/\/doi.org\/10.1186\/1477-7827-9-86.","DOI":"10.1186\/1477-7827-9-86"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_006","doi-asserted-by":"crossref","unstructured":"Brown, J, Farquhar, C, Beck, J, Boothroyd, C, Hughes, E. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 2009:CD002249. https:\/\/doi.org\/10.1002\/14651858.CD002249.pub4.","DOI":"10.1002\/14651858.CD002249.pub4"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_007","doi-asserted-by":"crossref","unstructured":"Adeoye, O, Olawumi, J, Opeyemi, A, Christiania, O. Review on the role of glutathione on oxidative stress and infertility. JBRA Assist Reprod 2018;22:61\u20136. https:\/\/doi.org\/10.5935\/1518-0557.20180003.","DOI":"10.5935\/1518-0557.20180003"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_008","doi-asserted-by":"crossref","unstructured":"Sacchinelli, A, Venturella, R, Lico, D, Di Cello, A, Lucia, A, Rania, E, et al.. The efficacy of inositol and N-acetyl cysteine administration (ovaric HP) in improving the ovarian function in infertile women with PCOS with or without insulin resistance. Obstet Gynecol Int 2014;2014:141020. https:\/\/doi.org\/10.1155\/2014\/141020.","DOI":"10.1155\/2014\/141020"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_009","doi-asserted-by":"crossref","unstructured":"Lasram, MM, Dhouib, IB, Annabi, A, El Fazaa, S, Gharbi, N. A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development. Clin Biochem 2015;48:1200\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.04.017.","DOI":"10.1016\/j.clinbiochem.2015.04.017"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_010","unstructured":"Hurst, GA, Shaw, PB, LeMaistre, CA. Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine. Am Rev Respir Dis 1967;96:962\u201370. https:\/\/doi.org\/10.1164\/arrd.1967.96.5.962."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_011","doi-asserted-by":"crossref","unstructured":"Lee, C-K, Weaks, RL, Johnson, GA, Bazer, FW, Piedrahita, JA. Effects of protease inhibitors and antioxidants on in\u00a0vitro survival of porcine primordial germ cells. Biol Reprod 2000;63:887\u201397. https:\/\/doi.org\/10.1095\/biolreprod63.3.887.","DOI":"10.1095\/biolreprod63.3.887"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_012","doi-asserted-by":"crossref","unstructured":"Cheraghi, E, Mehranjani, MS, Shariatzadeh, MA, Esfahani, MH, Ebrahimi, Z. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev 2016;28:723\u201331. https:\/\/doi.org\/10.1071\/rd14182.","DOI":"10.1071\/RD14182"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_013","doi-asserted-by":"crossref","unstructured":"Bedaiwy, MA, RezkH, Al Inany, A, Falcone, T. N-acetyl cystein improves pregnancy rate in long standing unexplained infertility: a novel mechanism of ovulation induction. Fertil Steril 2004;82:S228. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.07.604.","DOI":"10.1016\/j.fertnstert.2004.07.604"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_014","doi-asserted-by":"crossref","unstructured":"Abu Hashim, H, Anwar, K, El-Fatah, RA. N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. J Womens Health (Larchmt) 2010;19:2043\u20138. https:\/\/doi.org\/10.1089\/jwh.2009.1920.","DOI":"10.1089\/jwh.2009.1920"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_015","doi-asserted-by":"crossref","unstructured":"Mostajeran, F, Tehrani, HG, Rahbary, B. N-acetylcysteine as an adjuvant to letrozole for induction of ovulation in infertile patients with polycystic ovary syndrome. Adv Biomed Res 2018;7:100. https:\/\/doi.org\/10.4103\/abr.abr_157_17.","DOI":"10.4103\/abr.abr_157_17"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_016","unstructured":"Mofeed, FM, Wafa, AY, Haider, AM. Effect of N-acetylcysteine as an adjuvant to clomiphene citrate for induction of ovulation in\u00a0patients with polycystic ovary syndrome. EJPMR 2017;4:05\u201310."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_017","doi-asserted-by":"crossref","unstructured":"Rizk, AY, Bedaiwy, MA, Al-Inany, HG. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005;83:367\u201370. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.07.960.","DOI":"10.1016\/j.fertnstert.2004.07.960"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_018","doi-asserted-by":"crossref","unstructured":"Badawy, A, Baker El Nashar, A, El Totongy, M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertil Steril 2006;86:647\u201350. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.02.097.","DOI":"10.1016\/j.fertnstert.2006.02.097"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_019","unstructured":"PRISMA. PRISMA checklist; 2015. Available from: http:\/\/prisma-statement.org\/prismastatement\/Checklist.aspx [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_020","doi-asserted-by":"crossref","unstructured":"Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_021","unstructured":"Tool RoB. Current version of RoB 2 2019. Available at: https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2 [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_022","unstructured":"metafor: meta-analysis package for R 2019. Available from: https:\/\/cran.r-project.org\/web\/packages\/metafor\/index.html [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_023","doi-asserted-by":"crossref","unstructured":"Lin, L, Chu, H. Quantifying publication bias in meta-analysis. Biometrics 2018;74:785\u201394. https:\/\/doi.org\/10.1111\/biom.12817.","DOI":"10.1111\/biom.12817"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_024","unstructured":"Meta: general package for meta-analysis 2019. Available from: https:\/\/cran.r-project.org\/web\/packages\/meta\/index.html [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_025","doi-asserted-by":"crossref","unstructured":"Gayatri, K, Jena, S, Kumar, B. Metformin and N-acetyl cysteine in polycystic ovarian syndrome\u00a0\u2013 a comparative study. Indian J Clin Med 2010;2010:1\u20137.","DOI":"10.1177\/117739361000100002"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_026","doi-asserted-by":"crossref","unstructured":"Nasr, A. Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study. Reprod Biomed Online 2010;20:403\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2009.12.012.","DOI":"10.1016\/j.rbmo.2009.12.012"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_027","doi-asserted-by":"crossref","unstructured":"Salehpour, S, Sene, AA, Saharkhiz, N, Sohrabi, MR, Moghimian, F. N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2012;38:1182\u20136. https:\/\/doi.org\/10.1111\/j.1447-0756.2012.01844.x.","DOI":"10.1111\/j.1447-0756.2012.01844.x"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_028","unstructured":"Salehpour, S, Tohidi, M, Akhoond, M, Amirzargar, N. N acetyl cysteine, a novel remedy for poly cystic ovarian syndrome. Int J Fertil Steril 2008;3."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_029","doi-asserted-by":"crossref","unstructured":"Behrouzi Lak, T, Hajshafiha, M, Nanbakhsh, F, Oshnouei, S. N-acetyl cysteine in ovulation induction of PCOS women underwent intrauterine insemination: an RCT. Int J Reprod Biomed (Yazd) 2017;15:203\u20138. https:\/\/doi.org\/10.29252\/ijrm.15.4.203.","DOI":"10.29252\/ijrm.15.4.203"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_030","doi-asserted-by":"crossref","unstructured":"Nemati, M, Nemati, S, Taheri, AM, Heidari, B. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome. J Gynecol Obstet Hum Reprod 2017;46:579\u201385. https:\/\/doi.org\/10.1016\/j.jogoh.2017.07.004.","DOI":"10.1016\/j.jogoh.2017.07.004"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_031","unstructured":"EISaed, N, Abdel-latif, M, Abdel-Gawad, M, El-Gamal, H, Othman, Y. Adjuvant use of N-acetyl-cysteine with clomiphene citrate in polycystic ovary syndrome after ovarian drilling: a randomized controlled trial. Austin J Obstet Gynecol 2018;5:1093."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_032","doi-asserted-by":"crossref","unstructured":"Maged, AM, Elsawah, H, Abdelhafez, A, Bakry, A, Mostafa, WA. The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with Polycystic Ovary Syndrome. Gynecol Endocrinol 2015:1\u20134. https:\/\/doi.org\/10.3109\/09513590.2015.1037269.","DOI":"10.3109\/09513590.2015.1037269"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_033","doi-asserted-by":"crossref","unstructured":"Elnashar, A, Fahmy, M, Mansour, A, Ibrahim, K. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertil Steril 2007;88:406\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.11.173.","DOI":"10.1016\/j.fertnstert.2006.11.173"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_034","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_035","doi-asserted-by":"crossref","unstructured":"DeUgarte, CM, Bartolucci, AA, Azziz, R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454\u201360. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.11.070.","DOI":"10.1016\/j.fertnstert.2004.11.070"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_036","doi-asserted-by":"crossref","unstructured":"Mathur, R, Alexander, CJ, Yano, J, Trivax, B, Azziz, R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol 2008;199:596\u2013609. https:\/\/doi.org\/10.1016\/j.ajog.2008.09.010.","DOI":"10.1016\/j.ajog.2008.09.010"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_037","doi-asserted-by":"crossref","unstructured":"Victor, VM, Rocha, M, Ba\u00f1uls, C, Alvarez, A, de Pablo, C, Sanchez-Serrano, M, et al.. Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 2011;96:3115\u201322. https:\/\/doi.org\/10.1210\/jc.2011-0651.","DOI":"10.1210\/jc.2011-0651"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_038","doi-asserted-by":"crossref","unstructured":"Fenkci, V, Fenkci, S, Yilmazer, M, Serteser, M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123\u20137. https:\/\/doi.org\/10.1016\/s0015-0282(03)00571-5.","DOI":"10.1016\/S0015-0282(03)00571-5"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_039","doi-asserted-by":"crossref","unstructured":"Mattia, G, Bravi, MC, Laurenti, O, Cassone-Faldetta, M, Proietti, A, De Luca, O, et al.. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia 1998;41:1392\u20136. https:\/\/doi.org\/10.1007\/s001250051082.","DOI":"10.1007\/s001250051082"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_040","unstructured":"World Health Organzation. Sexual and reproductive health 2020. Available from: https:\/\/www.who.int\/reproductivehealth\/topics\/infertility\/definitions\/en\/ [Accessed 9 Dec 2019]."},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_041","doi-asserted-by":"crossref","unstructured":"Dunson, DB, Colombo, B, Baird, DD. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002;17:1399\u2013403. https:\/\/doi.org\/10.1093\/humrep\/17.5.1399.","DOI":"10.1093\/humrep\/17.5.1399"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_042","doi-asserted-by":"crossref","unstructured":"Sharma, R, Biedenharn, KR, Fedor, JM, Agarwal, A. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol 2013;11:66. https:\/\/doi.org\/10.1186\/1477-7827-11-66.","DOI":"10.1186\/1477-7827-11-66"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_043","doi-asserted-by":"crossref","unstructured":"Mejia, RB, Summers, KM, Kresowik, JD, Van Voorhis, BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2019;111:571\u20138.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.11.030.","DOI":"10.1016\/j.fertnstert.2018.11.030"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_044","doi-asserted-by":"crossref","unstructured":"Showell, MG, Mackenzie-Proctor, R, Jordan, V, Hart, RJ. Antioxidants for female subfertility. Cochrane Database Syst Rev 2017;7:CD007807. https:\/\/doi.org\/10.1002\/14651858.CD007807.pub3.","DOI":"10.1002\/14651858.CD007807.pub3"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_045","doi-asserted-by":"crossref","unstructured":"Thakker, D, Raval, A, Patel, I, Walia, R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int 2015;2015:817849. https:\/\/doi.org\/10.1155\/2015\/817849.","DOI":"10.1155\/2015\/817849"},{"key":"2025121209192885119_j_jbcpp-2020-0107_ref_046","doi-asserted-by":"crossref","unstructured":"Zegers-Hochschild, F, Adamson, GD, de Mouzon, J, Ishihara, O, Mansour, R, Nygren, K, et al.. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Fertil Steril 2009;24:2683\u20137. https:\/\/doi.org\/10.1093\/humrep\/dep343.","DOI":"10.1093\/humrep\/dep343"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jbcpp\/ahead-of-print\/article-10.1515-jbcpp-2020-0107\/article-10.1515-jbcpp-2020-0107.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2020-0107\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2020-0107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:08:53Z","timestamp":1765541333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2020-0107\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,12,14]]},"published-print":{"date-parts":[[2021,9,23]]}},"alternative-id":["10.1515\/jbcpp-2020-0107"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2020-0107","relation":{},"ISSN":["2191-0286"],"issn-type":[{"value":"2191-0286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]}}}